Drug repurposing is attracting growing attention as a strategy to address unmet medical needs by identifying new uses for existing medicines. Against this backdrop, the Reagan-Udall Foundation for the FDA,…
Jake Fairnie12 August 2026
REMEDi4ALL and iDR26 features in a RARE Revolution insider piece on “Drug repurposing: translating optimism into action for rare diseases” highlighting discussions at the conference and outlining ongoing hurdles related to realising the full potential of drug repurposing.
tools@teamitresearch.com29 July 2026
Prof. Zoltán Kaló, co-founder of REMEDi4ALL partner organisation Syreon Research Institute, has been appointed Director General of Hungary’s National Health Insurance Fund, taking up a senior leadership position within the newly formed Hungarian Government. Prof….
tools@teamitresearch.com10 July 2026
At iDR26, Nikoleta Efthymiopoulou, REMEDi4ALL Scientific Project Management Assistant, presented a poster exploring the prevalence and…
tools@teamitresearch.com30 June 2026
REMEDi4ALL and iDR26 features in a RARE Revolution insider piece on “Drug repurposing: translating optimism into action for rare diseases” highlighting discussions at the conference and outlining ongoing hurdles related to realising the full potential of drug repurposing.
tools@teamitresearch.com18 June 2026
A new REMEDi4ALL publication in Nature Reviews Drug Discovery contributes to the ongoing discussion on…
tools@teamitresearch.com15 June 2026
Ahead of the International Drug Repurposing Conference (iDR26), the REMEDi4ALL Funders Network gathered in Brussels…
tools@teamitresearch.com3 June 2026
Over 250 people gathered at Maison de la Poste in Brussels on 12–13 May 2026…
tools@teamitresearch.com18 May 2026
REMEDi4ALL Researchers have published new work in Health Policy OPEN identifying, shortlisting and examining perceptions of critical barriers in drug repurposing using a multi-stakeholder…
tools@teamitresearch.com4 May 2026
REMEDi4ALL Researchers have published a new study in Patterns analysing a comprehensive in-vitro dataset of >5000 repurposing compounds to develop an AI-based…
tools@teamitresearch.com28 April 2026
REMEDi4ALL features in a Reader’s Digest piece on “How AI is saving lives: Artificial intelligence can find new uses for existing drugs, helping to treat rare diseases, including the one that almost killed Joseph Coates” with an interview from REMEDi4ALL Scientific Coordinator Donald Lo.
tools@teamitresearch.com10 April 2026
REMEDi4ALL is pleased to announce the publication of its Funders Network White Paper: a comprehensive overview…
tools@teamitresearch.com18 March 2026
This week, REMEDi4ALL welcomed researchers from across Europe to the Wellcome Genome Campus, Cambridge for the second edition…
tools@teamitresearch.com13 March 2026
In this series, we talk to early career researchers from REMEDi4ALL institutions to find out…
tools@teamitresearch.com2 March 2026
On 28 February, the rare disease community will come together to mark Rare Disease Day, a campaign to raise awareness for the 300…
Max Adams26 February 2026
REMEDi4ALL is pleased to announce that the MOI‑A study, one of the REMEDi4ALL demonstrator projects,…
tools@teamitresearch.com14 January 2026
A multinational research team called TREATKCNQ is working closely together with patient families and advocacy groups…
tools@teamitresearch.com1 December 2025
The REMEDi4ALL consortium recently published a systematic literature review in the British Journal of Pharmacology,…
tools@teamitresearch.com12 November 2025
14 early career researchers (ECRs) from 10 countries joined drug repurposing experts near Montserrat, Barcelona, for the…
tools@teamitresearch.com13 October 2025
REMEDi4ALL researchers based at the Institute for Molecular Medicine Finland (FIMM) have recently published an article…
tools@teamitresearch.com29 September 2025
Sign up to receive the latest project-related news and opportunities
You can unsubscribe at any time.
